ADPT · Categories · Upgrades
ADPT - Analyst upgrades
Adaptive Biotechnologies Corporation (ADPT) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for ADPT
- Adaptive Biotechnologies upgraded by Goldman with a new price targetGoldman upgraded Adaptive Biotechnologies from Neutral to Buy and set a new price target of $9.00
- Adaptive Biotechnologies upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Adaptive Biotechnologies from Neutral to Overweight and set a new price target of $14.00 from $7.50 previously